Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quanterix Corp
(NQ:
QTRX
)
17.35
-0.53 (-2.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Quanterix Corp
< Previous
1
2
3
Next >
Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
June 07, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Releases Operating Results for First Quarter 2023
May 09, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix’s First Quarter 2023 Earnings Conference Call
May 02, 2023
From
Quanterix Corporation
Via
Business Wire
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
April 25, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in Barclays Global Healthcare Conference
March 08, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations
March 06, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at Cowen’s 43rd Annual Health Care Conference
February 28, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call
February 24, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces Appointment of Brian Blaser to Board of Directors
January 09, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
January 09, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
December 05, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force
November 16, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation Releases Operating Results for Third Quarter 2022
November 08, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix’ Third Quarter 2022 Earnings Conference Call
November 01, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces the Resignation of Kevin Hrusovsky as Executive Chairman of Board of Directors
August 08, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation Releases Operating Results for Second Quarter 2022, Announces Business Re-Alignment Plan and Revises 2022 Guidance
August 08, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in the Canaccord Genuity 42nd Annual Growth Conference
August 03, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix’ Second Quarter 2022 Earnings Conference Call
August 01, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications in the U.S.
July 27, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
June 09, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces Appointment of Karen A. Flynn to Board of Directors
June 06, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation Releases Operating Results for First Quarter 2022
May 10, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022
May 03, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis
April 22, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix’ Simoa® Technology Powers Large, International Comprehensive Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Disease Activity in Multiple Sclerosis (MS) Patients
April 04, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
February 23, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Receives Funding from the Alzheimer’s Drug Discovery Foundation to Accelerate Alzheimer’s Disease Diagnostic Plasma Test Development
March 29, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in the SVB Leerink Global Healthcare Conference
February 09, 2022
From
Quanterix Corporation
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.